Predictive Values of Presepsin Levels in ASciteS in Patients With Chronic Liver Failure
Recruiting
Observational Study
Ascites Hepatic
Liver Failure
Cirrhosis, Liver
No Placebo Group
Every participant receives an active treatment — no one gets a placebo.
No Study Drug
Researchers observe your health over time — no experimental treatment is given.
At a Glance
- Age
- 18 and older
- Sex
- Any
- Study type
- Observational
- Participants needed
- 30 (estimated)
- Sponsor
- Carol Davila University of Medicine and Pharmacy · Other
Think this trial could be right for you?
Answer a few quick questions to see if you may meet the eligibility requirements.
Check Your Eligibility
About This Trial
The investigators aim to study the predictive value of presepsin in ascites in newly admitted patients with chronic liver failure.
Trial Locations
Loading…
Loading trial locations…
Eligibility Criteria
Inclusion Criteria:
* patient with ascites and chronic liver failure
* no contraindications and technical possibility to perform diagnostic paracentesis
* age above 18 years old
* informed consent
Exclusion Criteria:
* contraindications to paracentesis or technical impossibility to perform parace…
Contacts